Renowned as experts in drowsiness/wakefulness detection, Optalert is now exploring new pathways in the automotive industry, pharmaceutical drug trials and neurological research. Sign up today to keep up to date with the latest news from Optalert.
Dr Murray John’s latest publication – Now available
The Assessment of ‘Sleepiness’ in Human Drug Trials: A New Perspective
Current Psychopharmacology 2019, Volume 8, Issue 1
OPTALERT’S EARLY-WARNING SYSTEM IS TRUSTED BY MAJOR GLOBAL BLUE CHIP COMPANIES
